Ryan & Maniskas, LLP Announces Investigation of NuVasive, Inc.

WAYNE, Pa., Aug. 9, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/nuva) announces that it is investigating potential claims against NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company") on behalf of those who purchased NuVasive common stock between January 1, 2007 and July 23, 2013 (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO )

The investigation concerns whether NuVasive and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On July 30, 2013, NuVasive revealed in a regulatory filing that it received a subpoena from the Office of the Inspector General of the U.S. Department of Health and Human Services (OIG) in connection with an investigation into possible false or otherwise improper claims submitted to Medicare and Medicaid. The subpoena seeks documents for the period January 2007 through April 2013. On this news announcement, shares of NuVasive fell $3.28 per share or 13% to close at $22.82 on July 31, 2013.

For more information regarding this, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at rmaniskas@rmclasslaw.com or visit: www.rmclasslaw.com/cases/nuva. For more information about class action cases in general or to learn more about Ryan & Maniskas, LLP, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

SOURCE Ryan & Maniskas, LLP